-
18
-
Imiquimod enhances IFN-γ production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.pdf
- Imiquimod enhances IFN-γ production and effector function of T cells infiltrating human squamous cell carcinomas of the skin
-
-
11
-
Imiquimod 3.75 Cream Applied Daily to Treat Anogenital Warts Combined Results from Women in Two Randomized, Placebo-Controlled Studies.pdf
- Imiquimod 3.75 Cream Applied Daily to Treat Anogenital Warts Combined Results from Women in Two Randomized, Placebo-Controlled StudiesImiquimod 3.75 Cream Applied Daily to Treat Anogenital Warts Combined Results from Women in Two Randomized, Placebo-Controlled StudiesImiquimod 3.75 Cream Applied Daily to Treat Anogenital Warts Combined Results from Women in Two Randomized, Placebo-Controlled Studies
-
-
10
-
Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORCIL-17A pathway modulation.pdf
- Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORCIL-17A pathway modulation
-
-
10
-
imiquimod-induced clearance of hpv is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.pdf
- imiquimod-induced clearance of hpv is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia
-
-
11
-
immunomodulatory effect of imiquimod through ccl22 produced by tumor-associated macrophages in b16f10 melanomas.[2017][anticancer res][.pdf
- immunomodulatory effect of imiquimod through ccl22 produced by tumor-associated macrophages in b16f10 melanomas.[2017][anticancer res][
-
-
10
-
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses a single-centre, double-blind, randomised, controll...pdf
- Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses a single-centre, double-blind, randomised, controlled phase 2b3 trial
-
-
16
-
lanolin-based organogel of salicylic acid evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in balbc mice model.[2.pdf
- lanolin-based organogel of salicylic acid evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in balbc mice model.[2
-
-
11
-
the use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules_ increasing penetration and adhesion of imiquimod in vaginal tissue..pdf
- the use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules_ increasing penetration and adhesion of imiquimod in vaginal tissue.
-
-
14
-
the potential of diosgenin in treating psoriasis_ studies from hacat keratinocytes and imiquimod-induced murine model.[2020][life sci].pdf
- the potential of diosgenin in treating psoriasis_ studies from hacat keratinocytes and imiquimod-induced murine model.[2020][life sci]
-
向豆丁求助:有没有imiquimod?